Clinical Trials Directory

Trials / Unknown

UnknownNCT02355353

Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer

Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer Treated With Fluoropyrimidine-based Chemotherapy as Preoperative Treatment

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
31 (estimated)
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to correlate the percentage change in apparent diffusion coefficient (ADC) between baseline and early therapy (at day 14) with tumor regression grade (TRG) measured in the surgical resection specimen.

Detailed description

This is a prospective, multicenter, single-arm imaging trial. Patients with resectable liver metastases from colorectal cancer (CRC) will undergo Diffusion Weighted Imaging- Magnetic Resonance Imaging (DWI-MRI) scans at least at three separate occasions: at baseline, at 14 days (maximum +/- 1 days deviation is acceptable) after first administration of chemotherapy and finally after up to 6 cycles of chemotherapy (one week prior to surgery). All patients registered in the study may participate to the test-retest analysis. This analysis required a double baseline scans (called test-retest) to be done on two separate occasions, separated from each other by from one hour to one week but both before start of therapy. The repeated scan at baseline (retest) is optional as it will be used only for the test-retest repeatability analysis. Dedicated in-house developed software will be used to quantify ADC to assess tumor characteristics and response to therapy.

Conditions

Interventions

TypeNameDescription
OTHERExperimental: imaging armDWI-MRI scans at baseline, at 14 days after first administration of chemotherapy and after up to 6 cycles of chemotherapy

Timeline

Start date
2015-02-01
Primary completion
2016-09-01
Completion
2017-02-01
First posted
2015-02-04
Last updated
2015-02-04

Source: ClinicalTrials.gov record NCT02355353. Inclusion in this directory is not an endorsement.